Literature DB >> 13749443

Observations on secondary malabsorption syndromes of intestinal origin. Regional enteritis, lymphoma, jejunal diverticulosis, gastrojejunocolic fistula.

H H SCUDAMORE.   

Abstract

Entities:  

Keywords:  GASTRIC FISTULA/complications; ILEITIS, REGIONAL/complications; INTESTINAL FISTULA/complications; INTESTINE, SMALL/neoplasms; JEJUNUM/diseases; LYMPHOMA/complications; SPRUE/etiology

Mesh：

Year:  1961        PMID： 13749443     DOI： 10.7326/0003-4819-55-3-433

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  8 in total

1.  Evaluation of 200 D(plus)-xylose blood level time curves as an index of intestinal absorption.

Authors:  I T BECK; S RONA; R D McKENNA; D S KAHN
Journal:  Am J Dig Dis       Date:  1962-10

2.  Chilblain lupus erythematosus as a manifestation of lymphoma.

Authors:  R Marks; H Baker; R H Marten; S C Gold
Journal:  Proc R Soc Med       Date:  1967-05

Review 3.  Nutritional disturbances in Crohn's disease.

Authors:  A D Harries; R V Heatley
Journal:  Postgrad Med J       Date:  1983-11       Impact factor: 2.401

4.  Primary gastrointestinal lymphoma.

Authors:  P Isaacson
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1981

5.  Intestinal lymphoma and sprue: a systematic approach.

Authors:  W Dutz; S Asvadi; S Sadri; E Kohout
Journal:  Gut       Date:  1971-10       Impact factor: 23.059

6.  Steatorrhea and malignant lymphoma. The relationship of malignant tumors of lymphoid tissue and celiac disease.

Authors:  W I Austad; J S Cornes; K R Gough; C F McCarthy; A E Read
Journal:  Am J Dig Dis       Date:  1967-05

7.  Coeliac disease, gluten-free diet, and malignancy.

Authors:  G K Holmes; P L Stokes; T M Sorahan; P Prior; J A Waterhouse; W T Cooke
Journal:  Gut       Date:  1976-08       Impact factor: 23.059

8.  Intestinal reticulosis as a complication of idiopathic steatorrhoea.

Authors:  K R GOUGH; A E READ; J M NAISH
Journal:  Gut       Date:  1962-09       Impact factor: 23.059
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.